Hikma Pharmaceuticals PLC (id:3285 HIK)
1,950.00 GBP
Opening hours: 08:00 - 16:30 (GMT Standard Time: 11/22/2024 5:37:53 PM)
Exchange closed, opens in 2 days 14 hours
About Hikma Pharmaceuticals PLC
Market Capitalization 4.05B
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
| Headquarters (address) |
1 New Burlington Place London W1S 2HR United Kingdom |
| Phone | 44 20 7399 2760 |
| Website | https://www.hikma.com |
| Employees | 9,100 |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | HIK |
| Exchange | London Stock Exchange |
| Currency | GBP |
| 52 week range | 1,711.00 - 2,165.00 |
| Market Capitalization | 4.05B |
| Dividend yield forward | 6.94 % |
| Dividend yield forward United Kingdom (ID:3, base:499) | 7.31 % |
| P/E trailing | 27.67 |
| P/E forward | 10.26 |
| Price/Sale | 1.34 |
| Price/Book | 177.13 |
| Beta | 0.435 |
| EPS | 0.660 |
| EPS United Kingdom (ID:3, base:637) | 0.428 |
Dividend growth streak
Hikma Pharmaceuticals PLC has raised their dividend 5.00 years in a row. This is above the 4.481461 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Hikma Pharmaceuticals PLC has raised their dividend 6.94 years in a row. This is below the 41168.086800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Hikma Pharmaceuticals PLC has raised their dividend 10.91 years in a row. This is below the 24.005000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Hikma Pharmaceuticals PLC has raised their dividend 14.23 years in a row. This is above the 12.571400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Hikma Pharmaceuticals PLC has raised their dividend 19.14 years in a row. This is above the 10.153400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Hikma Pharmaceuticals PLC has raised their dividend 72.75 years in a row. This is below the 147.100200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
Hikma Pharmaceuticals PLC years needed to self fund. This is below the 62.385563 year average in the 'Drug Manufacturers Specialty & Generic' industry
Dividend growth streak
Hikma Pharmaceuticals PLC has raised their dividend 5.00 years in a row. This is above the 4.481461 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Hikma Pharmaceuticals PLC has raised their dividend 6.94 years in a row. This is below the 41168.086800 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Hikma Pharmaceuticals PLC has raised their dividend 10.91 years in a row. This is below the 24.005000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Hikma Pharmaceuticals PLC has raised their dividend 14.23 years in a row. This is above the 12.571400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Hikma Pharmaceuticals PLC has raised their dividend 19.14 years in a row. This is above the 10.153400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Hikma Pharmaceuticals PLC has raised their dividend 72.75 years in a row. This is below the 147.100200 year average in the 'Drug Manufacturers Specialty & Generic' industry
Self funded year
Hikma Pharmaceuticals PLC years needed to self fund. This is below the 62.385563 year average in the 'Drug Manufacturers Specialty & Generic' industry